The company's low P/E ratio of 14.1x, compared to the market...
The company's low P/E ratio of 14.1x, compared to the market average in China, is due to expectations of limited future growth. The share price is unlikely to rise significantly in the near future under these circumstances.
Lacklustre Performance Is Driving Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) 26% Price Drop
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment